Hamilton Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$3.16M
Hamilton Pharmaceuticals General Information
Description
Developer of medical treatments for diseases related to central nervous system. The company engages in the development of late-stage products for neurology and psychiatry.
Contact Information
Corporate Office
- 1825 K Street Northwest
- Suite 520
- Washington, DC 20006
- United States
Corporate Office
- 1825 K Street Northwest
- Suite 520
- Washington, DC 20006
- United States
Hamilton Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 15-Oct-2007 | $3.16M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 22-Apr-2005 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Oct-2004 | Completed | Startup |
Hamilton Pharmaceuticals Patents
Hamilton Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-1874300-A2 | Method for treating apathy syndrome | Active | 20-Apr-2005 | ||
| US-20060241144-A1 | Method for treating apathy syndrome | Inactive | 20-Apr-2005 | ||
| EP-1874300-B1 | Method for treating apathy syndrome | Inactive | 20-Apr-2005 | ||
| EP-1874300-A4 | Method for treating apathy syndrome | Active | 20-Apr-2005 | ||
| ES-2311537-T3 | Use of nefiracetam in the treatment of postchemical neurodegeneration. | Inactive | 22-Aug-2001 | A61K31/40 |
Hamilton Pharmaceuticals Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CNF Investments | PE/Buyout | Minority | ||
| Index Ventures | Venture Capital | Minority | ||
| Vivo Capital | Venture Capital | Minority |
Hamilton Pharmaceuticals FAQs
-
When was Hamilton Pharmaceuticals founded?
Hamilton Pharmaceuticals was founded in 2004.
-
Where is Hamilton Pharmaceuticals headquartered?
Hamilton Pharmaceuticals is headquartered in Washington, DC.
-
What industry is Hamilton Pharmaceuticals in?
Hamilton Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Hamilton Pharmaceuticals a private or public company?
Hamilton Pharmaceuticals is a Private company.
-
What is the current valuation of Hamilton Pharmaceuticals?
The current valuation of Hamilton Pharmaceuticals is .
-
What is Hamilton Pharmaceuticals’s current revenue?
The current revenue for Hamilton Pharmaceuticals is .
-
How much funding has Hamilton Pharmaceuticals raised over time?
Hamilton Pharmaceuticals has raised $11M.
-
Who are Hamilton Pharmaceuticals’s investors?
CNF Investments, Index Ventures, and Vivo Capital have invested in Hamilton Pharmaceuticals.
-
When was Hamilton Pharmaceuticals acquired?
Hamilton Pharmaceuticals was acquired on 15-Oct-2007.
-
Who acquired Hamilton Pharmaceuticals?
Hamilton Pharmaceuticals was acquired by Neuren Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
